2026-10-18T23:54:09Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/requestoai:ebyu-rdlopen.rawdatalibrary.net:ebyu/166092026-10-18T20:36:29Zopenairedrivercom_ebyu_10000col_ebyu_10001Effect of Thiamine Pyrophosphate on Amiodarone-Induced Oxidative Kidney Damage in RatsDagel, TuncayMammadov, RenadBulut, SevalYeter, BahtinurTastan, Tugba BalEkici, OzgurCoban, Taha AbdulkadirSuleyman, HalisAmiodaroneantioxidantfree oxygen radicalskidneyoxidative damagethiamine pyrophosphateratISCHEMIA-REPERFUSIONSTRESSNEPHROTOXICITYEXTRACTPharmacology & PharmacyBackground and Objective: Amiodarone-induced kidney damage is associated with an increase in oxidant and proinflammatory cytokines. This study was planned to investigate the effect of thiamine pyrophosphate (TPP) on amiodarone-induced oxidative and inflammatory kidney damage in rats on both a biochemical and histopathological basis. Materials and Methods: Albino Wistar-type male rats (6 rats per group) were divided into healthy (HG), amiodarone (ADG) and amiodarone+TPP (TAG) groups. The TPP (20 mg kg(-1)) and amiodarone (50 mg kg(-1)) treatment continued for 14 days. Analyzes of oxidant, antioxidant and proinflammatory cytokines in excised kidney tissues and creatinine and blood urea nitrogen in serum were performed. Results: The amiodarone treated rats showed an increase in malondialdehyde, tumor necrosis factor, interleukin 1 beta, interleukin 6 levels, serum creatinine and blood urea nitrogen in the kidney tissue while a decrease was observed in total glutathione as compared to healthy animals (p<0.001). In addition, histopathological damage occurred in the kidney tissues of the ADG group. It was determined that TPP prevented biochemical changes and histopathological damage significantly (p<0.001). Conclusion: By acting as an antioxidant and anti-inflammatory, TPP might protect kidney tissue from amiodarone-induced damage.ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET2023Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/16609https://doi.org/10.3923/ijp.2023.521.5301811-7775enINTERNATIONAL JOURNAL OF PHARMACOLOGYinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/16609